Neoplasia Press Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Neoplasia Press General Information

Description

Publisher of journals. The company publishes journals in the field of oncology research.

Contact Information

Website
www.neoplasia.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2410 Foxway Drive
  • Ann Arbor, MI 48105
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Media and Information Services (B2B)
Acquirer
Elsevier
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 2410 Foxway Drive
  • Ann Arbor, MI 48105
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neoplasia Press Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neoplasia Press‘s full profile, request access.

Request a free trial

Neoplasia Press Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Neoplasia Press Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20060123348-A1 System and method for facilitating the pre-publication peer review process Active 07-Apr-2000
US-7007232-B1 System and method for facilitating the pre-publication peer review process Inactive 07-Apr-2000
US-7539938-B2 System and method for facilitating the pre-publication peer review process Inactive 07-Apr-2000 G06F40/174

Neoplasia Press FAQs

  • When was Neoplasia Press founded?

    Neoplasia Press was founded in 1998.

  • Where is Neoplasia Press headquartered?

    Neoplasia Press is headquartered in Ann Arbor, MI.

  • What industry is Neoplasia Press in?

    Neoplasia Press’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Neoplasia Press a private or public company?

    Neoplasia Press is a Private company.

  • What is Neoplasia Press’s current revenue?

    The current revenue for Neoplasia Press is .

  • When was Neoplasia Press acquired?

    Neoplasia Press was acquired on 06-Jan-2015.

  • Who acquired Neoplasia Press?

    Neoplasia Press was acquired by Elsevier.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »